Literature DB >> 23270987

Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition.

Neil S Lamarre1, Robert B Raffa, Ronald J Tallarida.   

Abstract

BACKGROUND: Cocaine has long been known to increase blood pressure, but the degree and mechanism of vasoconstricting action remain poorly understood. Here we examine the interaction between cocaine and alpha-adrenoceptor agonists, with the action of reuptake inhibition minimized.
METHODS: Cocaine was administered to isolated rings of rat thoracic aorta, alone and in combination with three different adrenoceptor agonists: phenylephrine, methoxamine, and norepinephrine. Synergy analysis begins with the predicted additive effect of the combination of two agonists, based upon dose equivalence theory. This case where one agonist (cocaine) has no effect when administered alone requires only a t-test to demonstrate that a departure from additivity has occurred.
RESULTS: At doses where cocaine alone produced no vasoconstriction, it potentiated the vasoconstriction produced by all three alpha agonists, a clear indication of synergism between cocaine and these agents. Higher doses of cocaine in combination with alpha adrenoceptor agents gave an inverted-U shaped (hormetic) dose-effect curve, i.e., dose-related relaxation at higher doses. The hormetic dose-effect relation was analyzed using computational methodology based on dose equivalence to derive the unknown second component of action that causes relaxation.
CONCLUSIONS: Cocaine exhibits both vasoconstricting and vasorelaxant effects. This relaxing component, possibly related to activation of myosin light chain phosphatase, was quantified as a dose-effect curve. Most important is the synergism between cocaine and alpha-adrenoceptor stimulation which cannot be explained as an action due to reuptake inhibition, and has not been previously described.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270987      PMCID: PMC3612562          DOI: 10.1016/j.drugalcdep.2012.11.020

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  25 in total

Review 1.  Smooth muscle contraction and relaxation.

Authors:  R Clinton Webb
Journal:  Adv Physiol Educ       Date:  2003-12       Impact factor: 2.288

2.  Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians.

Authors:  Robert B Raffa; Gregory W Stagliano; Ronald J Tallarida
Journal:  Eur J Pharmacol       Date:  2006-10-27       Impact factor: 4.432

3.  Evidence of cocaine-related coronary atherosclerosis in young patients with myocardial infarction.

Authors:  Roberto Patrizi; Vincenzo Pasceri; Alessandro Sciahbasi; Francesco Summaria; Giuseppe M C Rosano; Ernesto Lioy
Journal:  J Am Coll Cardiol       Date:  2006-04-24       Impact factor: 24.094

4.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

5.  Cocaine facilitates the effects of alpha-agonists and antagonists on adrenergic neurotransmission.

Authors:  D Nigro; M A Enero
Journal:  Gen Pharmacol       Date:  1981

Review 6.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

7.  Alpha-noradrenergic receptors modulate the development and expression of cocaine sensitization.

Authors:  Carlos A Jiménez-Rivera; Monica Feliu-Mojer; Rafael Vázquez-Torres
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

Review 8.  Cardiovascular disorders associated with cocaine use: myths and truths.

Authors:  Mark M Knuepfer
Journal:  Pharmacol Ther       Date:  2003-03       Impact factor: 12.310

9.  Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both.

Authors:  D J Moliterno; J E Willard; R A Lange; B H Negus; J D Boehrer; D B Glamann; C Landau; J D Rossen; M D Winniford; L D Hillis
Journal:  N Engl J Med       Date:  1994-02-17       Impact factor: 91.245

10.  On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data.

Authors:  Ronald J Tallarida; Alan Cowan; Robert B Raffa
Journal:  Drug Alcohol Depend       Date:  2010-01-12       Impact factor: 4.492

View more
  1 in total

1.  Elucidation of the profound antagonism of contractile action of phenylephrine in rat aorta effected by an atypical sympathomimetic decongestant.

Authors:  Eldina Rizvić; Goran Janković; Miroslav M Savić
Journal:  Korean J Physiol Pharmacol       Date:  2017-06-26       Impact factor: 2.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.